Jump to content

Metabolic alkalosis

From Wikipedia, the free encyclopedia
(Redirected from Hyperbicarbonatemia)
Metabolic alkalosis
Davenport diagram
SpecialtyEndocrinology, nephrology

Metabolic alkalosis is an acid-base disorder in which the pH of tissue is elevated beyond the normal range (7.35–7.45). This is the result of decreased hydrogen ion concentration, leading to increased bicarbonate (HCO3), or alternatively a direct result of increased bicarbonate concentrations. The condition typically cannot last long if the kidneys are functioning properly.

Signs and symptoms

[edit]

Mild cases of metabolic alkalosis often cause no symptoms. Typical manifestations of moderate to severe metabolic alkalosis include abnormal sensations, neuromuscular irritability, tetany, abnormal heart rhythms (usually due to accompanying electrolyte abnormalities such as low levels of potassium in the blood), coma, seizures, and temporary waxing and waning confusion.[citation needed]

Causes

[edit]

The causes of metabolic alkalosis can be divided into two categories, depending upon urine chloride levels.[1]

Chloride-responsive (Urine chloride < 25 mEq/L)

[edit]
  • Loss of hydrogen ions – Most often occurs via two mechanisms, either vomiting or via the kidney.[citation needed]
    • Vomiting results in the loss of hydrochloric acid (hydrogen and chloride ions) with the stomach contents. In the hospital setting this can commonly occur from nasogastric suction tubes.
    • Severe vomiting also causes loss of potassium (hypokalemia) and sodium (hyponatremia). The kidneys compensate for these losses by retaining sodium in the collecting ducts at the expense of hydrogen ions (sparing sodium/potassium pumps to prevent further loss of potassium), leading to metabolic alkalosis.[2]
  • Congenital chloride diarrhea – rare for being a diarrhea that causes alkalosis instead of acidosis.[3]
  • Contraction alkalosis – This results from a loss of water in the extracellular space, such as from dehydration. Decreased extracellular volume triggers the renin-angiotensin-aldosterone system, and aldosterone subsequently stimulates reabsorption of sodium (and thus water) within the nephron of the kidney. However, a second action of aldosterone is to stimulate renal excretion of hydrogen ions (while retaining bicarbonate), and it is this loss of hydrogen ions that raises the pH of the blood.
    • Diuretic therapyloop diuretics and thiazides can both initially cause increase in chloride, but once stores are depleted, urine excretion will be below < 25 mEq/L. The loss of fluid from sodium excretion causes a contraction alkalosis. Diuretic abuse among athletes[4] and people with eating disorders[5] may present with metabolic alkalosis.
  • Posthypercapnia – Hypoventilation (decreased respiratory rate) causes hypercapnia (increased levels of CO2), which results in respiratory acidosis. Renal compensation with excess bicarbonate retention occurs to lessen the effect of the acidosis. Once carbon dioxide levels return to base line, the higher bicarbonate levels reveal themselves putting the patient into metabolic alkalosis.[citation needed]
  • Cystic fibrosis – excessive loss of sodium chloride in the sweat leads to contraction of the extracellular volume in the same way as contraction alkalosis, as well chloride depletion.[6]
  • Alkalotic agents – Alkalotic agents, such as bicarbonate (administered in cases of peptic ulcer or hyperacidity) or antacids, administered in excess can lead to an alkalosis.[citation needed]

Chloride-indeterminate alkalosis

[edit]
  • Milk alkali syndrome
  • Blood product administration since this contains sodium citrate which is then metabolized into sodium bicarbonate. Typically, this is seen with large volume transfusions such as more than 8 units.[6]
  • Decreases in albumin and phosphate will cause metabolic alkalosis.[7]

Chloride-resistant (Urine chloride > 20 mEq/L)

[edit]

Compensation

[edit]

Compensation for metabolic alkalosis occurs mainly in the lungs, which retain carbon dioxide (CO2) through slower breathing, or hypoventilation (respiratory compensation). CO2 is then consumed toward the formation of the carbonic acid intermediate, thus decreasing pH. Respiratory compensation, though, is incomplete. The decrease in [H+] suppresses the peripheral chemoreceptors, which are sensitive to pH. But, because respiration slows, there is an increase in pCO2 which would cause an offset of the depression because of the action of the central chemoreceptors which are sensitive to the partial pressure of CO2[citation needed] in the cerebral spinal fluid. So, because of the central chemoreceptors, respiration rate would be increased.

Renal compensation for metabolic alkalosis, less effective than respiratory compensation, consists of increased excretion of HCO3 (bicarbonate), as the filtered load of HCO3 exceeds the ability of the renal tubule to reabsorb it.[citation needed]

To calculate the expected pCO2 in the setting of metabolic alkalosis, the following equations are used:

  • pCO2 = 0.7 [HCO3] + 20 mmHg ± 5
  • pCO2 = 0.7 [HCO3] + 21 mmHg[9]

Treatment

[edit]

To effectively treat metabolic alkalosis, the underlying cause(s) must be corrected. A trial of intravenous chloride-rich fluid is warranted if there is a high index of suspicion for chloride-responsive metabolic alkalosis caused by loss of gastrointestinal fluid (e.g., due to vomiting).[citation needed]

Terminology

[edit]
  • Alkalosis refers to a process by which the pH is increased.
  • Alkalemia refers to a pH which is higher than normal, specifically in the blood.

See also

[edit]

References

[edit]
  1. ^ "Alkalosis, Metabolic: eMedicine Pediatrics: Cardiac Disease and Critical Care Medicine". Retrieved 2009-05-10.
  2. ^ Hennessey, Iain. Japp, Alan.Arterial Blood Gases Made Easy. Churchill Livingstone 1 edition (18 Sep 2007).
  3. ^ Hirakawa, M.; Hidaka, N.; Kido, S.; Fukushima, K.; Kato, K. (2015). "Congenital Chloride Diarrhea: Accurate Prenatal Diagnosis Using Color Doppler Sonography to Show the Passage of Diarrhea". Journal of Ultrasound in Medicine. 34 (11): 2113–2115. doi:10.7863/ultra.15.01011. ISSN 0278-4297. PMID 26446821.
  4. ^ Cadwallader, Amy B; De La Torre, Xavier; Tieri, Alessandra; Botrè, Francesco (September 2010). "The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis: Diuretics in sport doping". British Journal of Pharmacology. 161 (1): 1–16. doi:10.1111/j.1476-5381.2010.00789.x. PMC 2962812. PMID 20718736.
  5. ^ Mascolo, Margherita; Chu, Eugene S.; Mehler, Philip S. (April 2011). "Abuse and clinical value of diuretics in eating disorders therapeutic applications". International Journal of Eating Disorders. 44 (3): 200–202. doi:10.1002/eat.20814. PMID 20186716.
  6. ^ a b Bates, C. M.; Baum, M.; Quigley, R. (1997-02-01). "Cystic fibrosis presenting with hypokalemia and metabolic alkalosis in a previously healthy adolescent". Journal of the American Society of Nephrology. 8 (2): 352–355. doi:10.1681/ASN.V82352. ISSN 1046-6673. PMID 9048354.
  7. ^ Miller's Anesthesia, 8th Edition, Chapter 60, 1811–1829
  8. ^ Cho Kerry C, "Chapter 21. Electrolyte & Acid-Base Disorders" (Chapter). McPhee SJ, Papadakis MA: CURRENT Medical Diagnosis & Treatment 2011: http://www.accessmedicine.com/content.aspx?aID=10909.
  9. ^ Hasan, Ashfaq. "The Analysis of Blood Gases." Handbook of Blood Gas/Acid-Base Interpretation. Springer London, 2013. pp. 253–266.
[edit]